ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 895

Incidence of Osteoporotic Mayor Fractures in a Cohort of Patients with Polymyalgia Rheumatica

Luciano Enrique Pompermayer1, Ignacio Javier Gandino1, Maximiliano José Martinez1, Florencia Beatriz Mollerach1, Marina Scolnik2, Javier Rosa1 and Enrique R. Soriano1, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 2Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Argentina., Buenos Aires, Argentina

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: fractures, osteoporosis and polymyalgia rheumatica

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Polymyalgia rheumatica (PMR) is an inflammatory disease associated with older age and long term use of glucocorticoids. As such a high incidence of osteoporosis and osteoporosis related fractures is expected. There is scarce information on incidence of osteoporotic-fractures in PMR in developing countries.The objective of this study was to identify the incidence rate and risk factors for osteoporotic-fractures in PMR patients.

Methods:  we retrospectively reviewed electronic medical records (EMR) of patients registered in a large University hospital between years 2000-2015 with the diagnosis of PMR. Patients fulfilling ACR PMR 2012 criteria or with a clinical diagnose made by a rheumatologist were included. Patients with previous history of fractures, or with traumatic fractures were excluded. The major osteoporotic fractures (hip, wrist, and clinical spine) retrieved from the EMR, during the follow up period were taken as the endpoint event. Global, and sex-specific incidence rate with their 95% CI was calculated. A Cox proportional hazards models was fitted to analyze variables associated with suffering a fracture, including age, sex, smoking, hypertension, obesity, time on steroids, and steroids initial dose.

Results:  998 patients contributing a total of 4283 patient-years were included. Patient characteristics are shown in the table. During follow up 93 fractures were observed, for an overall incident rate (cases per 1000 patient-years) of 21.7 (95% CI: 17.7-26.6), 26.3 (95% CI: 21.2-32.5) for women, and 8.3 (95% CI: 4.3-15.9) for men. Forty-three incident osteoporotic hip fractures were observed for an overall incident rate of 10 (95% CI: 7.4-13.5) per/1000 patient-years, 12.5 (95% CI: 9.2-17) for women, and 2.8 (95% CI: 0.9-8.5) for men. The incident rate (cases per 1000 patient-years) for wrist and clinical vertebral fractures were: overall: 7 (95% CI: 4.9-10); 9 (95% CI: 6.3-13) for women, and 0.9 (95% CI: 0.13-6.5) for men; and 4.7 (95% CI: 3-7.2), 4.7 (95% CI: 2.8-7.8) for women, and 4.6 (95% CI: 1.9-11) for men, respectively. In the univariate analysis patients with fractures were significantly more females, of older age, and received steroids for a longer period (table). In the multivariate Cox proportional hazards model, the only variables associated with osteoporotic fractures were female sex (HR: 2.7 (95% CI: 1.6-4.6), and older age at diagnosis (HR: 1.1 (95% CI: 1-1.1).

Conclusion:  There was a high incidence rate of major osteoporotic fractures among patients with PMR. Females and patients with older age were at higher risk. This risk should be taken into account when treating this disease. Table 1 Patients characteristics

Variable Patients with Fractures (n=93) Patients without Fractures (n=905) P Value
Females, n (%) 84 (90) 654 (72) <0.001
Mean age at diagnosis (SD) 77.1 (6.6) 75.3 (7.9) 0.0280
Bilateral shoulder aching, n (%) 92 (99) 878 (97) 0.259
Bilateral pelvic girdle (hip) aching 64 (69) 616 (68) 0.885
Peripheral synovitis (distal swelling, tenosynovitis or arthritis 8 (8.7) 118 (13) 0.234
Mean erythrocyte sedimentation rate (SD) 59.4 (25.3) 56.4 (25.4) 0.3024
Mean Methyilprednisone initial dose (SD) 9.3 (4.47) 9.3 (4.4) 0.8825
Mean months on steroid treatment (SD) 27.7 (21.3) 23.4 (18.5) 0.0187

Disclosure: L. E. Pompermayer, None; I. J. Gandino, None; M. J. Martinez, None; F. B. Mollerach, None; M. Scolnik, None; J. Rosa, None; E. R. Soriano, Abbvie, 2,Pfizer Inc, 3,UCB, 2,Janssen Pharmaceutica Product, L.P., 2,Roche Pharmaceuticals, 2,Bristol-Myers Squibb, 2,Abbvie, 5,Pfizer Inc, 5,UCB, 5,Janssen Pharmaceutica Product, L.P., 5,Roche Pharmaceuticals, 5,Novartis Pharmaceutical Corporation, 5,Bristol-Myers Squibb, 5.

To cite this abstract in AMA style:

Pompermayer LE, Gandino IJ, Martinez MJ, Mollerach FB, Scolnik M, Rosa J, Soriano ER. Incidence of Osteoporotic Mayor Fractures in a Cohort of Patients with Polymyalgia Rheumatica [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/incidence-of-osteoporotic-mayor-fractures-in-a-cohort-of-patients-with-polymyalgia-rheumatica/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-of-osteoporotic-mayor-fractures-in-a-cohort-of-patients-with-polymyalgia-rheumatica/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology